Efficacy Observation of Treatment with Compound Shuanghua Tablets in Patients with Upper Respiratory Tract Infection
Fengli Liu
Abstract
Fengli Liu
Abstract
Objective:To observe the clinical efficacy of compound Shuanghua tablets in treating upper respiratory tract infection.Methods:239 cases of upper respiratory tract infection were randomized into treatment group and contral group.180 cases in treatment group were given compound Shuanghua tablets and 59 cases in control group were given compound Yuxingcao Tablets,treatment period is 3 days.Results:The total effective rate of the disease was 100% in treatment group,and was 96.6% in control group,indicating no significant difference in comparison(P0.05).The total effective rate of syndrome of TCM was 95% in treatment group,and was 93.2% in control group,indicating no significant difference in comparison(P0.05).Conclusion:Compound Shuanghua tablets and compound Yuxingcao tablets had equal efficacy.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To observe the clinical efficacy of compound Shuanghua tablets in treating upper respiratory tract infection.Methods:239 cases of upper respiratory tract infection were randomized into treatment group and contral group.180 cases in treatment group were given compound Shuanghua tablets and 59 cases in control group were given compound Yuxingcao Tablets,treatment period is 3 days.Results:The total effective rate of the disease was 100% in treatment group,and was 96.6% in control group,indicating no significant difference in comparison(P0.05).The total effective rate of syndrome of TCM was 95% in treatment group,and was 93.2% in control group,indicating no significant difference in comparison(P0.05).Conclusion:Compound Shuanghua tablets and compound Yuxingcao tablets had equal efficacy.
Key concepts: Medicine, Upper respiratory tract infection, Clinical efficacy, Respiratory tract, Respiratory tract infections, Significant difference, Treatment and control groups, Internal medicine